These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33791990)

  • 1. Metabolomics of Gastric Cancer.
    Kadam W; Wei B; Li F
    Adv Exp Med Biol; 2021; 1280():291-301. PubMed ID: 33791990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric cancer: Metabolic and metabolomics perspectives (Review).
    Xiao S; Zhou L
    Int J Oncol; 2017 Jul; 51(1):5-17. PubMed ID: 28535006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of metabolic reprogramming on the immune microenvironment in gastric cancer.
    Shang Z; Ma Z; Wu E; Chen X; Tuo B; Li T; Liu X
    Biomed Pharmacother; 2024 Jan; 170():116030. PubMed ID: 38128177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
    Liang Q; Wang C; Li B
    Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolite sensing and signaling in cancer.
    Wang YP; Li JT; Qu J; Yin M; Lei QY
    J Biol Chem; 2020 Aug; 295(33):11938-11946. PubMed ID: 32641495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomics, metabolic flux analysis and cancer pharmacology.
    Liang L; Sun F; Wang H; Hu Z
    Pharmacol Ther; 2021 Aug; 224():107827. PubMed ID: 33662451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Metabolomics Analysis in Tumor Metabolism Reprogramming.
    Han J; Li Q; Chen Y; Yang Y
    Front Mol Biosci; 2021; 8():763902. PubMed ID: 34901157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose metabolism in gastric cancer: The cutting-edge.
    Yuan LW; Yamashita H; Seto Y
    World J Gastroenterol; 2016 Feb; 22(6):2046-59. PubMed ID: 26877609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of metabolomics technologies toward cancer prognosis and therapy.
    Hoang G; Udupa S; Le A
    Int Rev Cell Mol Biol; 2019; 347():191-223. PubMed ID: 31451214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear magnetic resonance-based metabolomics and metabolic pathway networks from patient-matched esophageal carcinoma, adjacent noncancerous tissues and urine.
    Liang JH; Lin Y; Ouyang T; Tang W; Huang Y; Ye W; Zhao JY; Wang ZN; Ma CC
    World J Gastroenterol; 2019 Jul; 25(25):3218-3230. PubMed ID: 31333313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics and Metabolic Reprogramming in Kidney Cancer.
    Weiss RH
    Semin Nephrol; 2018 Mar; 38(2):175-182. PubMed ID: 29602399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic analysis reveals altered metabolic pathways in a rat model of gastric carcinogenesis.
    Gu J; Hu X; Shao W; Ji T; Yang W; Zhuo H; Jin Z; Huang H; Chen J; Huang C; Lin D
    Oncotarget; 2016 Sep; 7(37):60053-60073. PubMed ID: 27527852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
    Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
    J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities.
    De Matteis S; Ragusa A; Marisi G; De Domenico S; Casadei Gardini A; Bonafè M; Giudetti AM
    Oxid Med Cell Longev; 2018; 2018():7512159. PubMed ID: 30524660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics and cellular altered pathways in cancer biology: A review.
    Bhardwaj JK; Siwach A; Sachdeva SN
    J Biochem Mol Toxicol; 2024 Sep; 38(9):e23807. PubMed ID: 39148273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Trends in Gastrointestinal Cancer Targeted Therapies: Harnessing Tumor Microenvironment, Immune Factors, and Metabolomics Insights.
    Rauth S; Malafa M; Ponnusamy MP; Batra SK
    Gastroenterology; 2024 Oct; 167(5):867-884. PubMed ID: 38759843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer.
    Sun C; Wang A; Zhou Y; Chen P; Wang X; Huang J; Gao J; Wang X; Shu L; Lu J; Dai W; Bu Z; Ji J; He J
    Nat Commun; 2023 May; 14(1):2692. PubMed ID: 37164975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a mass spectrometry-based pseudotargeted metabolomics strategy to analyze hormone-stimulated gastric cancer cells.
    Li J; Wang Q; Zheng Y; Zhou P; Xu X; Liu X; Zhao L; Liu H
    J Pharm Biomed Anal; 2020 Feb; 180():113041. PubMed ID: 31855724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics for tumor marker discovery and identification based on chromatography-mass spectrometry.
    Yin P; Xu G
    Expert Rev Mol Diagn; 2013 May; 13(4):339-48. PubMed ID: 23638817
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.